glp-1 pancreatitis class action in kentucky SGLT2 vs GLP-1: Individualizing Diabetes, Cardiovascular, and Renal Outcomes Pancreatitis Warnings Strengthened on GLP-1RAs

The six-month study showed that patients who stuck to their medication (95% adherence at three months), regularly did strength training, and ate enough protein were more successful at preserving muscle mass

doi:10.17863/CAM.40216

Further, new studies now suggest patients taking GLP-1 drugs are twice as likely to develop Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)

Its also important to know that some may change your perception of sweet tastes without medication, says Dr

Formularies for plans available in 2024 were extracted from addresses listed in CMS Machine Readable URL File Public on February 28, 2024

Even if GLP-1s have lower efficacy than an existing treatment (and there are indications that they may have higher efficacy), if they can reach many times more people, the overall public health impact would be massive